NCT03250871

Brief Summary

Hypnosis has already shown to decrease pain and anxiety in different surgical specialities. Nevertheless, its input has never been studied in cardiology. This research is a prospective, monocentric, controlled and randomized study. Patients over 18 years old and hospitalized for atrial flutter ablation may be included and randomized into one of the arms: placebo or hypnosis. Global pain will be assessed by a visual analogue pain scale. Anxiety, morphine consumption, and patient sedation will also be assessed. The aim of this study is to improve the care given to patient undergoing atrial flutter ablation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 16, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

October 2, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 23, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2019

Completed
Last Updated

February 10, 2020

Status Verified

December 1, 2019

Enrollment Period

2 years

First QC Date

August 11, 2017

Last Update Submit

February 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Global pain self-assessment during the procedure

    Assessed with visual analogue pain scale

    Collected 45 min after the procedure

Secondary Outcomes (4)

  • Anxiety during the procedure

    Collected after the procedure

  • Morphine consumption

    Collected after the procedure

  • Patient sedation evaluation

    Collected after the procedure

  • Pain assessed prospectively during the procedure;

    Evaluated every 5 minutes during the procedure;

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Placebo will be the suggestion of self-relaxation methods (for example, "try to relax" ,"try to think of pleasant moment ") and the diffusion of "white noise" during surgery.

Other: Placebo

Hypnosis

EXPERIMENTAL

Hypnosis will be associated with the usual anesthesia. Hypnosis is a temporary modification of consciousness technique based on suggestion. It is divided into three phases: * induction: attention of the patient fixed on an object or a part of the body, * the dissociation where the patient cuts off auditory, visual and tactile perceptions, * and finally the opening towards a hypnotic experience thanks to the imaginary.

Other: Hypnosis

Interventions

Hypnosis will be supervised by a nurse trained by the French Institute of Hypnosis.

Hypnosis
PlaceboOTHER

Placebo consists in non-hypnotic relaxation suggestions and in hearing white noise through headphones

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old
  • Surgery ablation of atrial flutter
  • Agreement to participate of the study

You may not qualify if:

  • Person who does not speak French or deaf
  • Chronic pain with the visual analogue scale \> 5
  • Psychiatric pathology
  • Contraindication to paracetamol, lidocaine, morphine
  • Pregnant women, or breast-feeding women or without effective contraception

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU DE Poitiers

Poitiers, France

Location

MeSH Terms

Conditions

Atrial Flutter

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2017

First Posted

August 16, 2017

Study Start

October 2, 2017

Primary Completion

September 23, 2019

Study Completion

September 26, 2019

Last Updated

February 10, 2020

Record last verified: 2019-12

Locations